Nanopore Sequencing of a Forensic STR Multiplex Reveals Loci Suitable for Single-Contributor STR Profiling.


Journal

Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097

Informations de publication

Date de publication:
01 04 2020
Historique:
received: 09 03 2020
revised: 24 03 2020
accepted: 31 03 2020
entrez: 5 4 2020
pubmed: 5 4 2020
medline: 27 3 2021
Statut: epublish

Résumé

Nanopore sequencing for forensic short tandem repeats (STR) genotyping comes with the advantages associated with massively parallel sequencing (MPS) without the need for a high up-front device cost, but genotyping is inaccurate, partially due to the occurrence of homopolymers in STR loci. The goal of this study was to apply the latest progress in nanopore sequencing by Oxford Nanopore Technologies in the field of STR genotyping. The experiments were performed using the state of the art R9.4 flow cell and the most recent R10 flow cell, which was specifically designed to improve consensus accuracy of homopolymers. Two single-contributor samples and one mixture sample were genotyped using Illumina sequencing, Nanopore R9.4 sequencing, and Nanopore R10 sequencing. The accuracy of genotyping was comparable for both types of flow cells, although the R10 flow cell provided improved data quality for loci characterized by the presence of homopolymers. We identify locus-dependent characteristics hindering accurate STR genotyping, providing insights for the design of a panel of STR loci suited for nanopore sequencing. Repeat number, the number of different reference alleles for the locus, repeat pattern complexity, flanking region complexity, and the presence of homopolymers are identified as unfavorable locus characteristics. For single-contributor samples and for a limited set of the commonly used STR loci, nanopore sequencing could be applied. However, the technology is not mature enough yet for implementation in routine forensic workflows.

Identifiants

pubmed: 32244632
pii: genes11040381
doi: 10.3390/genes11040381
pmc: PMC7230633
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

J Hum Genet. 2020 Jan;65(1):21-24
pubmed: 31649301
Biotechniques. 2011 Aug;51(2):127-33
pubmed: 21806557
Electrophoresis. 2018 Nov;39(21):2642-2654
pubmed: 30101986
Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13770-3
pubmed: 8943010
Forensic Sci Int Genet. 2014 Sep;12:107-19
pubmed: 24908576
Forensic Sci Int Genet. 2015 Sep;18:78-89
pubmed: 25704953
Forensic Sci Int Genet. 2012 Dec;6(6):810-8
pubmed: 22503403
Nat Biotechnol. 2016 May 6;34(5):518-24
pubmed: 27153285
Sci Rep. 2017 Feb 03;7:41759
pubmed: 28155888
Genome Biol. 2019 Nov 14;20(1):239
pubmed: 31727106
Forensic Sci Int Genet. 2019 Jan;38:204-210
pubmed: 30448528
Anal Chem. 2019 May 21;91(10):6783-6789
pubmed: 31038923
Biosensors (Basel). 2016 Aug 05;6(3):
pubmed: 27527231
Forensic Sci Int Genet. 2012 Sep;6(5):646-52
pubmed: 22445421
Genome Biol. 2016 Nov 25;17(1):239
pubmed: 27887629

Auteurs

Olivier Tytgat (O)

Laboratory of Pharmaceutical Biotechnology, Ghent University, 9000 Gent, Belgium.
Department of Life Science Technologies, Imec, 3001 Leuven, Belgium.

Yannick Gansemans (Y)

Laboratory of Pharmaceutical Biotechnology, Ghent University, 9000 Gent, Belgium.

Jana Weymaere (J)

Laboratory of Pharmaceutical Biotechnology, Ghent University, 9000 Gent, Belgium.

Kaat Rubben (K)

Laboratory of Pharmaceutical Biotechnology, Ghent University, 9000 Gent, Belgium.

Dieter Deforce (D)

Laboratory of Pharmaceutical Biotechnology, Ghent University, 9000 Gent, Belgium.

Filip Van Nieuwerburgh (F)

Laboratory of Pharmaceutical Biotechnology, Ghent University, 9000 Gent, Belgium.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH